Published : Dec-2019
No. of Pages : 95
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Immunosuppressant Therapeutic Drug Monitoring Overview 7
3 Products under Development 8
3.1 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 8
3.2 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory 9
3.3 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path 10
3.4 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date 11
4 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products under Development by Companies 12
4.1 Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development 12
4.2 Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 13
5 Immunosuppressant Therapeutic Drug Monitoring Companies and Product Overview 15
5.1 Abbott Diagnostics Company Overview 15
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 BIOHOPE Scientific SL Company Overview 16
5.2.1 BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 16
5.3 Laboratory Corp of America Holdings Company Overview 17
5.3.1 Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 17
5.4 Ortho-Clinical Diagnostics Inc Company Overview 18
5.4.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.5 Progenika Biopharma SA Company Overview 22
5.5.1 Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Roche Diagnostics International Ltd Company Overview 23
5.6.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Siemens Healthcare Diagnostics Inc Company Overview 43
5.7.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 43
6 Immunosuppressant Therapeutic Drug Monitoring- Recent Developments 49
6.1 Nov 05, 2019: Thermo Fisher Scientific highlights expanded pharma services capabilities during CPhI 49
6.2 Oct 29, 2019: Waters reports third quarter 2019 financial results 50
6.3 Oct 23, 2019: Thermo Fisher Scientific reports third quarter 2019 results 51
6.4 Sep 24, 2019: Theradiag announces improved results for H1 2019 53
6.5 Sep 19, 2019: SenzaGen presents a new commercial organization and a new financial target 56
6.6 Sep 11, 2019: Mark Beaudouin to retire as Waters General Counsel; Company promotes Keeley Aleman 57
6.7 Sep 05, 2019: Thermo Fisher Scientific elects New Director to Board 57
6.8 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 58
6.9 Aug 28, 2019: Waters names Jonathan M. Pratt as President of TA Instruments 58
6.10 Aug 06, 2019: Aurinia reports second quarter 2019 financial results and operational highlights 59
7 Appendix 92
7.1 Methodology 92
7.2 About GlobalData 95
7.3 Contact Us 95
7.4 Disclaimer 95
List of Tables
Table 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 9
Table 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory 10
Table 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path 11
Table 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date 12
Table 5: Immunosuppressant Therapeutic Drug Monitoring Companies - Pipeline Products by Stage of Development 13
Table 6: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 14
Table 7: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 17
Table 8: Alinity i Assay - Methotrexate - Product Status 17
Table 9: Alinity i Assay - Methotrexate - Product Description 17
Table 10: BIOHOPE Scientific SL Pipeline Products & Ongoing Clinical Trials Overview 18
Table 11: Immunobiogram - Renal Transplantation - Product Status 18
Table 12: Immunobiogram - Renal Transplantation - Product Description 18
Table 13: Laboratory Corp of America Holdings Pipeline Products & Ongoing Clinical Trials Overview 19
Table 14: DoseASSURE RTX Assay - Product Status 19
Table 15: DoseASSURE RTX Assay - Product Description 19
Table 16: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 21
Table 17: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Status 21
Table 18: VITROS XT 7600 Integrated System - Cedia Cyclosporine Assay - Product Description 21
Table 19: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Status 22
Table 20: VITROS XT 7600 Integrated System - Cedia Mycophenolic Acid Assay - Product Description 22
Table 21: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Status 22
Table 22: VITROS XT 7600 Integrated System - Methotrexate Assay - Product Description 24
Table 23: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Status 24
Table 24: VITROS XT 7600 Integrated System - QMS Everolimus Assay - Product Description 24
Table 25: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Status 25
Table 26: VITROS XT 7600 Integrated System - QMS Tacrolimus Assay - Product Description 25
Table 27: Progenika Biopharma SA Pipeline Products & Ongoing Clinical Trials Overview 26
Table 28: Promonitor - Autoimmune And Inflammation - Product Status 26
Table 29: Promonitor - Autoimmune And Inflammation - Product Description 26
Table 30: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 28
Table 31: Cobas - Cyclosporin A Assay - Product Status 30
Table 32: Cobas - Cyclosporin A Assay - Product Description 30
Table 33: Cobas - Everolimus Assay - Product Status 31
Table 34: Cobas - Everolimus Assay - Product Description 31
Table 35: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Status 31
Table 36: Cobas 4000 Analyzer Series With e 411 Module - Cyclosporine Assay - Product Description 32
Table 37: Cobas 4000 Analyzer Series With e 411 Module - Sirolimus Assay - Product Status 32
Table 38: Cobas 4000 Analyzer Series With e 411 Module - Sirolimus Assay - Product Description 32
Table 39: Cobas 4000 Analyzer Series With e 411 Module - Sirolimus Assay - Product Status 33
Table 40: Cobas 4000 Analyzer Series With e 411 Module - Sirolimus Assay - Product Description 33
Table 41: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Status 33
Table 42: Cobas 6000 Analyzer Series With c 501 Module - Cyclosporine Assay - Product Description 33
Table 43: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Status 34
Table 44: Cobas 6000 Analyzer Series With c 501 Module - Everolimus Assay - Product Description 34
Table 45: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Status 34
Table 46: Cobas 6000 Analyzer Series With c 501 Module - Sirolimus Assay - Product Description 35
Table 47: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Status 35
Table 48: Cobas 6000 Analyzer Series With c 501 Module - Tacrolimus Assay - Product Description 35
Table 49: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Status 35
Table 50: Cobas 6000 Analyzer Series With e 601 Module - Cyclosporine Assay - Product Description 36
Table 51: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Status 36
Table 52: Cobas 6000 Analyzer Series With e 601 Module - Everolimus Assay - Product Description 36
Table 53: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Status 37
Table 54: Cobas 6000 Analyzer Series With e 601 Module - Sirolimus Assay - Product Description 38
Table 55: Cobas 6000 Analyzer Series With e 601 Module - Tacrolimus Assay - Product Status 38
Table 56: Cobas 6000 Analyzer Series With e 601 Module - Tacrolimus Assay - Product Description 38
Table 57: Cobas 8000 Analyzer Series With c 502 Module - Cyclosporine Assay - Product Status 38
Table 58: Cobas 8000 Analyzer Series With c 502 Module - Cyclosporine Assay - Product Description 39
Table 59: Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Status 39
Table 60: Cobas 8000 Analyzer Series With c 502 Module - Everolimus Assay - Product Description 39
Table 61: Cobas 8000 Analyzer Series With c 502 Module - Sirolimus Assay - Product Status 40
List of Figures
Figure 1: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Stage of Development 8
Figure 2: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Territory 9
Figure 3: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Regulatory Path 10
Figure 4: Immunosuppressant Therapeutic Drug Monitoring - Pipeline Products by Estimated Approval Date 11
